|
Leveraged Charitable Donation Programs
Crestor Side Effects
Depo-Provera Causes Bone Loss
LEVERAGED CHARITABLE DONATION PROGRAMS
We are investigating the possibility of a class proceeding claim relating to specific leveraged charitable donation programs.
Under these programs, donations are solicited and a portion of the funds paid by donors are donated to a charitable foundation with the donor borrowing the balance from a company said to be independent. Part of the cash donation is a security deposit on the loan that covers the difference between the amount actually paid and a total donation receipt.
The total donation receipt is for an amount in excess of the amount actually being paid in cash by the donor.
Some programs represent that the security deposit amount will be invested in a fund which will generate a return such that the returns will be used to fully satisfy the loan.
These programs allow participants to borrow approximately 85% of the total amount to be donated with only approximately 15% actually being provided in cash by the donor. A loan is obtained for the balance over a ten year period with donors being told that they will not be called upon to make payment of the loan.
The charitable donation credits being claimed by donors have been disallowed by the Canada Revenue Agency and some individuals are now being called upon to make payment of the loans.
We are investigating this situation with a view to possibly commencing action on behalf of donors who now find themselves being reassessed by Canada Revenue Agency, liable for payment of interest and penalties and facing the prospect of liability under the promissory notes executed in respect of the loans taken.
If you have any information in connection with leveraged charitable donation programs or have participated in such a program and wish to share your information with us, please feel free to contact us.
CRESTOR SIDE EFFECTS
The drug Crestor has been linked to kidney damage and kidney failure.
The manufacturer of the drug is AstraZeneca.
Crestor is in the family of cholesterol-lowering drugs called statins.
Several years ago, Baycol, another popular statin drug, was banned as a result of its link to a potentially fatal disease, Rhabdomyolysis.
Crestor was approved for sale in the United States by the FDA in August, 2003, after a delay because of safety concerns.
The FDA approved Crestor but at lower dosages then originally requested.
Records from the FDA and health agencies in Canada and Britain show life-threatening side effects occur even at the lower doses.
AstraZeneca has recently begun a public education campaign recommending that patients arm themselves with the most current information and speak to their physicians before making decisions about Crestor.
We are investigating the possibility of a class proceeding claim against AstraZeneca in connection with Crestor.
If you have any information in connection with this matter, please feel free to contact us.
DEPO-PROVERA CAUSES BONE LOSS
Depo-Provera is an injectable contraceptive.
The drug is manufactured and distributed by Pfizer Canada Inc. who recently said that women using the injectable contraceptive can lose significant bone mineral density, damage that may be irreversible and puts them at increased risk of developing osteoporosis.
This announcement has angered a Canadian coalition of women's health groups that started lobbying against the drug long before its approval in April, 1997. These groups argued that safety testing was inadequate.
Depo-Provera has been particularly popular with young women because it is not a daily pill. The drug is injected once every three months.
In Canada, almost 625,000 prescriptions were written for Depo-Provera last year.
That suggests that more than 150,000 Canadian women use injectable contraception.
Women who took Depo-Provera and who have experienced or may experience loss of bone mineral density may be entitled to compensation. We are investigating this matter.
If you have taken or are taking Depo-Provera, please contact us to provide us with information in respect of your situation. |
